Page last updated: 2024-09-03

nnc 112 and Dyskinesia, Medication-Induced

nnc 112 has been researched along with Dyskinesia, Medication-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gerlach, J; Jensen, G; Nicholson, K; Peacock, L	1

Other Studies

1 other study(ies) available for nnc 112 and Dyskinesia, Medication-Induced

Article	Year
Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys. European archives of psychiatry and clinical neuroscience, 1999, Volume: 249, Issue:5 Topics: Animals; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Male; Raclopride; Receptors, Dopamine D1; Time Factors	1999

Article

Year

Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys.

European archives of psychiatry and clinical neuroscience, 1999, Volume: 249, Issue:5

Topics: Animals; Basal Ganglia Diseases; Benzazepines; Benzofurans; Cebus; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Male; Raclopride; Receptors, Dopamine D1; Time Factors

1999